First time user? Click here for an essential guide on how to make the best experience of our virtual platform.

Welcome to the 8th Kidney Disease Clinical Trialists Workshop

Dear Colleagues,
I, along with my co-directors, have the immense pleasure of welcoming you back in the French Embassy in Washington DC, for the 8th edition of the Kidney Disease Clinical Trialists Workshop on March 15-16, 2024.

The Kidney Disease Clinical Trialists (KDCT) Workshop is a high level think-tank, with an exceptional expert faculty. It involves a limited number of attendees (90-100) and includes distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R&D pharma and device companies, NIH, EMA and FDA.

The KDCT Workshop aims to foster an international exchange of ideas where we will brainstorm on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for kidney disease.

Our objectives over the next 2 days are to produce relevant data from controlled kidney disease clinical trials (beyond cardiovascular outcomes trials) that will contribute to better clinical care and to understand the problems associated with making decisions about what constitutes relevant information, how to improve kidney disease clinical trials, and, as is commonly the case, how to satisfy regulatory authorities and payers.

We also welcome our colleagues who could not join us in person, and will be participating remotely using our virtual platform. Please do not hesitate to send your questions and join the discussion at any time.

Welcome to the KDCT 2024.

Professor Patrick Rossignol
Workshop Director

Workshop Co-Directors